Superficial nonampullary duodenal epithelial tumors are considered rare but have been increasingly recognized in recent years.Accordingly, the importance of endoscopic treatment for the lesions are also increasing. An endoscopic resection can be considered for duodenal adenoma and mucosal cancer. The choice of resection method should be made based on the size of the lesion, endoscopic findings, pathologic diagnosis, and risk of procedure-related complication. For small adenomas <10 mm in size, endoscopic mucosal resection (EMR), cold snare polypectomy, and underwater EMR can be considered. An en bloc or piecemeal resection using EMR or underwater EMR can be selected for 10-20 mm sized adenomas. For lesions ≥20 mm in size or suspicious for mucosal cancer, an endoscopic submucosal dissection followed by closure of the mucosal defect conducted by an experienced endoscopist is appropriate.

Gastric cancer remains a significant disease burden in Korea, with Helicobacter pylori infections being the most crucial risk factor.With the advent of next-generation sequencing, the role of gastric microbiota in gastric cancer has attracted increasing attention.Studies have shown that the gastric microbiota of patients with gastric cancer differs in composition from that of the controls, with reduced microbial diversity. Lactic acid bacteria and oral microflora are often enriched in gastric cancer and are believed to induce chronic inflammation or promote the production of nitroso compounds. This review focuses on recent studies comparing the gastric microbiome in gastric cancer patients and controls. (Korean J Gastroenterol 2023;81:235-242)

Superficial nonampullary duodenal epithelial tumors are considered rare but have been increasingly recognized in recent years.Accordingly, the importance of endoscopic treatment for the lesions are also increasing. An endoscopic resection can be considered for duodenal adenoma and mucosal cancer. The choice of resection method should be made based on the size of the lesion, endoscopic findings, pathologic diagnosis, and risk of procedure-related complication. For small adenomas <10 mm in size, endoscopic mucosal resection (EMR), cold snare polypectomy, and underwater EMR can be considered. An en bloc or piecemeal resection using EMR or underwater EMR can be selected for 10-20 mm sized adenomas. For lesions ≥20 mm in size or suspicious for mucosal cancer, an endoscopic submucosal dissection followed by closure of the mucosal defect conducted by an experienced endoscopist is appropriate.

Antiplatelet and anticoagulation agents are increasingly prescribed for secondary prophylaxis in patients with cardiovascular and cerebrovascular diseases. These drugs are associated with an increased risk of gastrointestinal bleeding, including peptic ulcer bleeding. It is difficult to decide when to restart the agents after peptic ulcer bleeding in these patients because the risk of rebleeding and thromboembolism should be balanced. The Korean College of Helicobacter and Upper Gastrointestinal Research revised the guidelines for drug-induced peptic ulcers as evidence-based guidelines using a de novo process. This paper introduces new recommendations on the resumption of antiplatelet and anticoagulation agents after peptic ulcer bleeding based on the revised guidelines for drug-induced peptic ulcers.

No abstract available.
Helicobacter pylori* ; Helicobacter* ; Stomach Neoplasms*

A 35-years-old man was hospitalized with gene-ralized edema. 6 months ago, the patient was operated by radical subtotal gastrectomy for advanced gastric adenocarcinoma. The patient presented with multiple liver metastasis and the massive proteinuria. The patients renal biopsy revealed minimal change nephrotic syndrome and treated with prednisolone and diuretics. The patient was improved clinical symptome and decreased 24 hours urine protein. In literature reviewed, gastric carcinoma was not associated with minimal change nephrotic syndrome. We experienced advanced gastric carcinoma associated with minimal change nephrotic syndrome, thus we report it.
Adenocarcinoma* ; Biopsy ; Diuretics ; Edema ; Gastrectomy ; Humans ; Liver* ; Neoplasm Metastasis* ; Nephrosis, Lipoid* ; Prednisolone ; Proteinuria

We retrospectively analyzed the CT (10 cases) and MR (5 cases) findings in 10 patients with radiation-induced pulmonary injury. On CT studies, 8 cases showed fibrotic change and 6 of them also showed solid consolidation with bronchiectasis. The differential diagnosis of radiation-induced injury from residual or recurrent tumor was possible on CT studies which was impossible on plain chest radiograph (2 cases) or MR study(1 case). On MR studies, 4 cases showed solid consolidation with bronchiectasis and fibrosis. The signal intensity was siointense compared with that of the muscle on T1WI (5 cases), and hyperintense of PDWI and T2WI(3 cases). The lesions enhanced well on Gd-DTPA enhanced study (4 cases). The residual or recurrent tumor showed the same signal intensity and degree of enhancement with radiation-induced injury (2 cases). CT and MR are useful for the evaluation of the anatomic details of the large overlapped area of increased density of the radiation-induced pulmonary injury on plain chest radiograph. But MR study is not superior to CT on the differentiation of the residual or recurrent tumor and radiation-induced injury because the tumor may show the same signal intensity and degree of enhancement with radiation-induced injury.
Bronchiectasis ; Diagnosis, Differential ; Fibrosis ; Gadolinium DTPA ; Humans ; Lung Injury* ; Radiography, Thoracic ; Retrospective Studies

PURPOSE: We conducted a retrospective analysis to determine if adjuvant chemotherapy prolongs overall survival in patients with pathologic stage IB lung adenocarcinoma who had undergone complete resection and were defined as high-risk by a newly developed recurrence risk scoring model. MATERIALS AND METHODS: Patients who underwent curative resection for stage IB lung adenocarcinoma were analyzed with a newly developed recurrence risk scoring model and divided into a low-risk group and a high-risk group. The patients in the high-risk group were retrospectively divided into two groups based on whether they underwent adjuvant chemotherapy or observation. Recurrence-free survival and overall survival were compared between these two groups. RESULTS: A total of 328 patients who underwent curative resection between 2000 and 2009 were included in this study, of whom 110 (34%) received adjuvant chemotherapy and 218 (67%) underwent observation without additional treatment. According to our risk model, 167 patients (51%) were high-risk and 161 (49%) were low-risk. The 5-year recurrence-free survival rates and overall survival were 84.4% and 91.5% in low-risk patients and 53.9% and 74.7% in high-risk patients (p < 0.001). In high-risk patients, the 5-year overall survival rates were 77% among patients who underwent observation and 87% among those who underwent adjuvant chemotherapy (p=0.019). CONCLUSION: Adjuvant chemotherapy prolonged overall survival among high-risk patients who had undergone complete resection for stage IB lung adenocarcinoma.
Adenocarcinoma* ; Chemotherapy, Adjuvant* ; Humans ; Lung* ; Recurrence* ; Retrospective Studies ; Survival Rate